The Peter Doherty Institute for Infection and Immunity
The Peter Doherty Institute for Infection and Immunity
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART | HIV-1-infection | Recruiting | Phase 1 / Phase 2 | 2026-09-17 | NCT05668026 | |
| Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia | S. Aureus Bacteremia; S. Aureus Bloodstream Infection; Staphylococcus Aureus Bacteremia; Staphylococcus Aureus Endocarditis; Staphylococcus Aureus Septicemia | Recruiting | Phase 4 | 2026-09-09 | NCT06637332 | |
| ROADMAP Clinical Trial | Large Joint Prosthetic Joint Infections; Prosthetic Joint Infections of Hip; Prosthetic Joint Infections of Knee | Recruiting | Phase 4 | 2026-07-27 | NCT06771050 | |
| Staphylococcus Aureus Network Adaptive Platform Trial | Bacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, staphylococcal infection | Recruiting | Phase 4 | 2026-05-06 | NCT05137119 | |
| The Optimising Isolation, Quarantine and Distancing Study for COVID-19 | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Not stated | 2026-01-13 | NCT07337382 | |
| COVID-19 Booster Study in Healthy Adults in Australia | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 3 | 2026-01-02 | NCT05658523 |